Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AvantorAVTR -1.69%61 EV-to-FCF is 25.28 as of Jul. 18, 2026, which is 15% below its 10-year median of 29.59. GuruFocus rates AVTR with a GF Score™ of 61/100 and a GF Value™ of $18.43 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Avantor ranks worse than 53.62% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Avantor's Enterprise Value is $11,095 Mil.
Avantor's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $439 Mil. Therefore, Avantor's EV-to-FCF for today is 25.28.
The historical rank and industry rank for Avantor's EV-to-FCF or its related term are showing as below:
AVTR'
s EV-to-FCF Range Over the Past 10 Years
Min: 17.39 Med: 29.59 Max: 77.23
Current: 25.28
During the past 10 years, the highest EV-to-FCF of Avantor was 77.23. The lowest was 17.39. And the median was 29.59.
AVTR's EV-to-FCF is ranked worse than 53.62% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.635
vs AVTR: 25.28
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-18), Avantor's stock price is $11.07.
Avantor's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.810. Therefore, Avantor's PE Ratio (TTM) for today is At Loss.
Avantor (NYSE:AVTR) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Avantor's share price for today is $11.07.
Avantor's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.810.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Avantor EV-to-FCF Related Terms
Avantor EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Avantor's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Avantor's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avantor EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avantor's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Avantor's EV-to-FCF falls into.
Avantor's current Enterprise Value is $11,095 Mil.
Avantor's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $439 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avantor (AVTR) has a EV-to-FCF of 25.28 as of Jul. 18, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Avantor and its competitors. This is 15% below median its historical median of 29.59. Over the past decade, Avantor's EV-to-FCF has ranged from 17.39 to 77.23. According to the industry distribution chart, Avantor ranks #222 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 53.6%.
Is Avantor's EV-to-FCF too high?
Avantor's current EV-to-FCF of 25.28 is 15% below median its 10-year median of 29.59. Over the past 10 years, this metric has ranged from a low of 17.39 to a high of 77.23. The Medical Devices & Instruments industry median EV-to-FCF is 23.64. Avantor's value of 25.28 is 7% above this industry median. Based on the distribution chart, Avantor ranks #222 out of 414 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avantor has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avantor's EV-to-FCF compare to ATR and TFX?
According to the Medical Devices & Instruments industry distribution chart, Avantor ranks #222 out of 414 companies for EV-to-FCF. This places Avantor in the lower half of its industry. The industry median EV-to-FCF is 23.64. Avantor's value of 25.28 is 7% above this benchmark. Historically, Avantor's own EV-to-FCF has ranged from 17.39 to 77.23 over the past decade. While the company's 10-year median is 29.59 vs. the industry median of 23.64, Avantor has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.64, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avantor's current EV-to-FCF of 25.28 is 7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Avantor and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avantor's current EV-to-FCF is 25.28, which is 15% below median its own 10-year median of 29.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avantor stock overvalued right now?
Based on GuruFocus' analysis, Avantor (AVTR) is currently considered Possible Value Trap. The stock's GF Value™ is $18.43, compared to a current price of $11.07 — trading 39.9% below its estimated fair value. The current EV-to-FCF is 25.28, which is 15% below median its 10-year median of 29.59 and 7% above the Medical Devices & Instruments industry median of 23.64. Avantor's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Avantor (AVTR), the current EV-to-FCF is 25.28 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avantor (AVTR) Overvalued in 2026?
Based on GuruFocus' analysis, Avantor stock appears to be undervalued.
The current stock price of $11.07 is trading 39.9% below its estimated GF Value™ of $18.43.
GuruFocus considers Avantor to be Possible Value Trap.
Key valuation signals for AVTR:
EV-to-FCF: 25.28 (15% below median its 10-year median of 29.59)
GF Value™: $18.43 vs. price of $11.07 (39.9% below fair value)
Industry Position: 7% above the Medical Devices & Instruments median (#222 of 414)
No single metric tells the full story. See the AVTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
61GF Score
Get the complete analysis for AVTR
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVTR has been successfully added to your 
